1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > China Cardiovascular Devices Market Outlook to 2020

China Cardiovascular Devices Market Outlook to 2020

  • May 2014
  • -
  • Global Data
  • -
  • 235 pages

China Cardiovascular Devices Market Outlook to 2020

Summary

GlobalData’s new report, "China Cardiovascular Devices Market Outlook to 2020", provides key market data on the China Cardiovascular Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiovascular Devices market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Cardiovascular Devices categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves.
- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
- 2012 company shares and distribution shares data for each of the market categories.
- Global corporate-level profiles of key companies operating within the China Cardiovascular Devices market.
- Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Abbott Laboratories, Cordis Corporation, C.R. Bard, Inc., Thoratec Corporation, Philips Healthcare, Sorin Group, MAQUET GmbH & Co. KG, Edwards Lifesciences Corporation, Terumo Corporation and BIOTRONIK SE & Co. KG.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

China Cardiovascular Devices Market Outlook to 2020
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 13
2.1 What Is This Report About? 13
2.2 Cardiovascular Devices Market Segmentation 13
2.3 Definitions of Markets Covered in the Report 16
3 Cardiovascular Devices Market, China 32
3.1 Cardiovascular Devices Market, China, Revenue ($m), 2005-2020 32
3.2 Cardiovascular Devices Market, China, Revenue Mix ($m), 2012 34
3.3 Cardiovascular Devices Market, China, Category Contribution by Revenue ($m), 2012 35
3.4 Cardiovascular Devices Market, China, Category Comparison by Revenue ($m), 2005-2020 37
3.5 Cardiovascular Devices Market, China, Revenue ($m), 2005-2012 39
3.6 Cardiovascular Devices Market, China, Revenue ($m), 2012-2020 41
3.7 Cardiovascular Devices Market, China, Volume (Units), 2005-2020 43
3.8 Cardiovascular Devices Market, China, Volume (Units), 2005-2012 45
3.9 Cardiovascular Devices Market, China, Volume (Units), 2012-2020 47
3.10 Cardiovascular Devices Market, China, Company Share by Revenue ($m), 2011-2012 49
4 Cardiac Assist Devices Market, China 51
4.1 Cardiac Assist Devices Market, China, Revenue Mix ($m), 2012 51
4.2 Cardiac Assist Devices Market, China, Segment Contribution (%), 2012 52
4.3 Cardiac Assist Devices Market, China, Revenue ($m), by Segment, 2005-2012 53
4.4 Cardiac Assist Devices Market, China, Revenue ($m) by Segment, 2012-2020 55
4.5 Cardiac Assist Devices Market, China, Volume (Units) by Segment, 2005-2012 57
4.6 Cardiac Assist Devices Market, China, Volume (Units) by Segment, 2012-2020 59
4.7 Cardiac Assist Devices Market, China, Distribution Share by Revenue ($m), 2011-2012 61
4.8 Cardiac Assist Devices Market, China, Company Share by Revenue ($m), 2011-2012 62
5 Cardiac Rhythm Management Market, China 64
5.1 Cardiac Rhythm Management Market, China, Revenue Mix ($m), 2012 64
5.2 Cardiac Rhythm Management Market, China, Segment Contribution (%), 2012 65
5.3 Cardiac Rhythm Management Market, China, Revenue ($m), by Segment, 2005-2012 66
5.4 Cardiac Rhythm Management Market, China, Revenue ($m) by Segment, 2012-2020 68
5.5 Cardiac Rhythm Management Market, China, Volume (Units) by Segment, 2005-2012 70
5.6 Cardiac Rhythm Management Market, China, Volume (Units) by Segment, 2012-2020 72
5.7 Cardiac Rhythm Management Market, China, Distribution Share, Revenue ($m), 2011-2012 74
5.8 Cardiac Rhythm Management Market, China, Company Share by Revenue ($m), 2011-2012 75
6 Cardiovascular Monitoring and Diagnostic Devices Market, China 77
6.1 Cardiovascular Monitoring and Diagnostic Devices Market, China, Revenue ($m), 2005-2012 77
6.2 Cardiovascular Monitoring and Diagnostic Devices Market, China, Revenue ($m), 2012-2020 79
6.3 Cardiovascular Monitoring and Diagnostic Devices Market, China, Volume (Units), 2005-2012 81
6.4 Cardiovascular Monitoring and Diagnostic Devices Market, China, Volume (Units), 2012-2020 82
6.5 Cardiovascular Monitoring and Diagnostic Devices Market, China, Distribution Share, Revenue ($m), 2011-2012 83
6.6 Cardiovascular Monitoring and Diagnostic Devices Market, China, Company Share by Revenue ($m), 2011-2012 84
7 Cardiovascular Prosthetic Devices Market, China 86
7.1 Cardiovascular Prosthetic Devices Market, China, Revenue Mix ($m), 2012 86
7.2 Cardiovascular Prosthetic Devices Market, China, Segment Contribution (%), 2012 87
7.3 Cardiovascular Prosthetic Devices Market, China, Revenue ($m), by Segment, 2005-2012 88
7.4 Cardiovascular Prosthetic Devices Market, China, Revenue ($m) by Segment, 2012-2020 90
7.5 Cardiovascular Prosthetic Devices Market, China, Volume (Units) by Segment, 2005-2012 92
7.6 Cardiovascular Prosthetic Devices Market, China, Volume (Units) by Segment, 2012-2020 94
7.7 Cardiovascular Prosthetic Devices Market, China, Distribution Share, Revenue ($m), 2011-2012 96
7.8 Cardiovascular Prosthetic Devices Market, China, Company Share by Revenue ($m), 2011-2012 97
8 Cardiovascular Surgery Market, China 99
8.1 Cardiovascular Surgery Market, China, Revenue Mix ($m), 2012 99
8.2 Cardiovascular Surgery Market, China, Segment Contribution (%), 2012 100
8.3 Cardiovascular Surgery Market, China, Revenue ($m), by Segment, 2005-2012 101
8.4 Cardiovascular Surgery Market, China, Revenue ($m) by Segment, 2012-2020 103
8.5 Cardiovascular Surgery Market, China, Volume (Units) by Segment, 2005-2012 105
8.6 Cardiovascular Surgery Market, China, Volume (Units) by Segment, 2012-2020 107
8.7 Cardiovascular Surgery Market, China, Distribution Share, Revenue ($m), 2011-2012 109
8.8 Cardiovascular Surgery Market, China, Company Share by Revenue ($m), 2011-2012 110
9 Electrophysiology Market, China 112
9.1 Electrophysiology Market, China, Revenue Mix ($m), 2012 112
9.2 Electrophysiology Market, China, Segment Contribution (%), 2012 113
9.3 Electrophysiology Market, China, Revenue ($m), by Segment, 2005-2012 114
9.4 Electrophysiology Market, China, Revenue ($m) by Segment, 2012-2020 116
9.5 Electrophysiology Market, China, Volume (Units) by Segment, 2005-2012 118
9.6 Electrophysiology Market, China, Volume (Units) by Segment, 2012-2020 120
9.7 Electrophysiology Market, China, Distribution Share, Revenue ($m), 2011-2012 122
9.8 Electrophysiology Market, China, Company Share by Revenue ($m), 2011-2012 123
10 External Defibrillators Market, China 125
10.1 External Defibrillators Market, China, Revenue ($m), 2005-2012 125
10.2 External Defibrillators Market, China, Revenue ($m), 2012-2020 126
10.3 External Defibrillators Market, China, Volume (Units), 2005-2012 127
10.4 External Defibrillators Market, China, Volume (Units), 2012-2020 128
10.5 External Defibrillators Market, China, Distribution Share, Revenue ($m), 2011-2012 129
10.6 External Defibrillators Market, China, Company Share by Revenue ($m), 2011-2012 130
11 Interventional Cardiology Market, China 132
11.1 Interventional Cardiology Market, China, Revenue Mix ($m), 2012 132
11.2 Interventional Cardiology Market, China, Segment Contribution (%), 2012 133
11.3 Interventional Cardiology Market, China, Revenue ($m), by Segment, 2005-2012 135
11.4 Interventional Cardiology Market, China, Revenue ($m) by Segment, 2012-2020 137
11.5 Interventional Cardiology Market, China, Volume (Units) by Segment, 2005-2012 139
11.6 Interventional Cardiology Market, China, Volume (Units) by Segment, 2012-2020 141
11.7 Interventional Cardiology Market, China, Distribution Share, Revenue ($m), 2011-2012 143
11.8 Interventional Cardiology Market, China, Company Share by Revenue ($m), 2011-2012 144
12 Peripheral Vascular Devices Market, China 146
12.1 Peripheral Vascular Devices Market, China, Revenue Mix ($m), 2012 146
12.2 Peripheral Vascular Devices Market, China, Segment Contribution (%), 2012 147
12.3 Peripheral Vascular Devices Market, China, Revenue ($m), by Segment, 2005-2012 149
12.4 Peripheral Vascular Devices Market, China, Revenue ($m) by Segment, 2012-2020 151
12.5 Peripheral Vascular Devices Market, China, Volume (Units) by Segment, 2005-2012 153
12.6 Peripheral Vascular Devices Market, China, Volume (Units) by Segment, 2012-2020 155
12.7 Peripheral Vascular Devices Market, China, Distribution Share, Revenue ($m), 2011-2012 157
12.8 Peripheral Vascular Devices Market, China, Company Share by Revenue ($m), 2011-2012 158
13 Prosthetic Heart Valves Market, China 160
13.1 Prosthetic Heart Valves Market, China, Revenue Mix ($m), 2012 160
13.2 Prosthetic Heart Valves Market, China, Segment Contribution (%), 2012 161
13.3 Prosthetic Heart Valves Market, China, Revenue ($m), by Segment, 2005-2012 162
13.4 Prosthetic Heart Valves Market, China, Revenue ($m) by Segment, 2012-2020 164
13.5 Prosthetic Heart Valves Market, China, Volume (Units) by Segment, 2005-2012 166
13.6 Prosthetic Heart Valves Market, China, Volume (Units) by Segment, 2012-2020 168
13.7 Prosthetic Heart Valves Market, China, Distribution Share, Revenue ($m), 2011-2012 170
13.8 Prosthetic Heart Valves Market, China, Company Share by Revenue ($m), 2011-2012 171
14 Overview of Key Companies in China, Cardiovascular Devices Market 173
14.1 Medtronic, Inc. 173
14.1.1 Company Overview 173
14.2 Lepu Medical Technology (Beijing) Co., Ltd. 173
14.2.1 Company Overview 173
14.3 Boston Scientific Corporation 173
14.3.1 Company Overview 173
14.4 Terumo Corporation 174
14.4.1 Company Overview 174
14.5 St. Jude Medical, Inc. 174
14.5.1 Company Overview 174
14.6 Abbott Laboratories 174
14.6.1 Company Overview 174
14.7 Biosensors International Group, Ltd. 175
14.7.1 Company Overview 175
14.8 Edwards Lifesciences Corporation 175
14.8.1 Company Overview 175
14.9 Cordis Corporation 175
14.9.1 Company Overview 175
14.10 Asahi Intecc Co., Ltd. 176
14.10.1 Company Overview 176
14.11 Biotronik SE and Co. KG 176
14.11.1 Company Overview 176
14.12 Sorin S.p.A. 176
14.12.1 Company Overview 176
14.13 Volcano Corporation 176
14.13.1 Company Overview 176
14.14 Covidien plc 177
14.14.1 Company Overview 177
14.15 Biosense Webster, Inc. 177
14.15.1 Company Overview 177
14.16 C. R. Bard, Inc. 177
14.16.1 Company Overview 177
14.17 Lifetech Scientific (Shenzhen) Co., Ltd. 178
14.17.1 Company Overview 178
14.18 Philips Healthcare 178
14.18.1 Company Overview 178
14.19 Maquet Holding B.V. and Co. KG. 178
14.19.1 Company Overview 178
15 Cardiovascular Devices Market Pipeline Products 179
16 Financial Deals Landscape 181
16.1 Acquisition 181
16.1.1 Lepu Medical Technology To Acquire Additional 24.9% Stake In Shaanxi Qinming Medical Instruments 181
16.1.2 MicroPort Acquires D-Pulse Medical 183
16.1.3 MicroPort Scientific Acquires Winning Forward For US$5.3 Million 184
16.1.4 Medtronic Completes Acquisition Of 26.4% Stake In LifeTech Scientific For US$66 Million 185
16.1.5 MicroPort Medical Acquires Dongguan Kewei Medical From Savernake Investments For Up To US$17 Million 187
16.2 Asset Transactions 189
16.2.1 AngioDynamics Completes Acquisition Of Rights To Microwave Ablation Technology For US$16 Million 189
16.3 Partnerships 191
16.3.1 Vasomedical And PSK Enter Into Joint Venture Agreement To Form VSK Medical 191
16.3.2 Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology 192
16.3.3 ReFlow Medical Enters Into Distribution Agreement With MicroPort Scientific 193
16.3.4 MicroPort Scientific To Form Joint Venture With Sorin 194
16.3.5 Sun Biomedical Plans To Enter Into Licensing Agreement With Parvulus Suisse 195
16.3.6 Xenios Enters Into Licensing Agreement With Leukocare For Next Generation Extracorporeal Support Systems 196
16.3.7 Micell Technologies Enters Into Co-Development Agreement With Hefei Life Science For MiStent SES 197
16.3.8 Coherex Medical Enters Into Distribution Agreement With Biosense Webster 198
16.3.9 Biosensors Enters Into Licensing Agreement With Eurocor 199
16.3.10 Terumo Enters Into Co-Development Agreement With Kaneka For PTA Balloon Catheters 201
16.3.11 TriReme Medical Enters Into Distribution Agreement With Weigao Medical Devices 202
16.3.12 Terumo Enters Into Agreement With Shanghai AngioCare Medical Technolgy 203
16.3.13 Biosensors Extends Licensing Agreement With Terumo For BioMatrix Technology 204
16.3.14 MicroPort Medical Forms Joint Venture With MicroPort Endovascular 205
16.3.15 Boston Scientific Enters Into Agreement With Philips Healthcare 206
16.3.16 CardioComm Solutions Enters Into Co-Development Agreement With Monebo Technologies For ECG Interpretation Software 207
17 Recent Developments 209
17.1 Corporate Communications 209
17.1.1 Dec 19, 2013: Mindray Announced Shareholder Resolutions Post 2013 Annual General Meeting 209
17.1.2 Dec 16, 2013: Deutsche Private Equity Completes Acquisition Of Zellbios, API Manufacturer 209
17.1.3 Dec 11, 2013: Appointment of Non-executive Director and Member of Nomination Committee 210
17.1.4 Nov 26, 2013: Mindray to Hold Annual General Meeting in Hong Kong on December 17, 2013 210
17.1.5 Jun 12, 2013: Mindray Medical Appoints Cheng Minghe As Co-CEO 210
17.2 Financial Announcements 211
17.2.1 Mar 03, 2014: Mindray Announces 2013 Fourth Quarter and Full Year Results 211
17.2.2 Jan 13, 2014: Mindray Announces Preliminary 2013 Operating Results and 2014 Net Revenue Guidance 213
17.2.3 Dec 19, 2013: Withdrawal of NTCELL pre-clinical study 214
17.2.4 Nov 04, 2013: Mindray Announces Third Quarter 2013 Financial Results 215
17.2.5 Oct 15, 2013: Mindray to Report Third Quarter 2013 Financial Results on Nov. 4, 2013 217
17.2.6 Aug 05, 2013: Mindray Announces Second Quarter 2013 Financial Results 217
17.2.7 Jul 16, 2013: Mindray to Report Second Quarter 2013 Financial Results on August 5, 2013 219
17.2.8 May 06, 2013: Mindray Reports Revenue Of $242.1m In Q1 2013 219
17.2.9 May 05, 2013: Kindstar Global Exercises Option For Licensing Agreement With BioView For Lung Cancer Test 221
17.3 Government and Public Interest 222
17.3.1 Apr 11, 2014: Oncolytics Biotech Collaborators Present Translational Brain Cancer Clinical Data and Immunomodulatory Preclinical Research at UK Oncolytic Virus Conference 222
17.3.2 Jan 02, 2014: Mindray to Participate in Upcoming Investor Conferences and Events 223
17.4 Legal And Regulatory 224
17.4.1 Nov 12, 2013: Mindray Announced a Settlement Agreement with Beckman Coulter 224
17.5 Other Significant Developments 224
17.5.1 Mar 12, 2014: Compumedics gets boost in China with key $2.0m contracts 224
17.5.2 Mar 07, 2014: Mindray Announces ADS Dividend Record Date for March 2014 Dividend 224
17.5.3 Jan 02, 2014: Response Biomedical Provides Update on Chinese Distribution Agreement with OandD Biotech 225
17.5.4 May 24, 2013: MicroPort Orthopedics Begins Construction At Suzhou Singapore Industrial Park, China 225
17.6 Product News 225
17.6.1 Nov 27, 2013: MicroPort Received CE Approval for FireMagic, EasyFinder, EasyLoop and FireMagic 3D 225
17.6.2 Jul 01, 2013: Merit Medical Announces Multiple Regulatory Approvals 226
18 Appendix 227
18.1 Research Methodology 228
18.1.1 Coverage 228
18.1.2 Secondary Research 228
18.1.3 Primary Research 229
18.1.4 Market Modeling and Forecasting 230
18.1.5 Company Share Analysis 233
18.1.6 Distribution Share Analysis 234
18.2 Expert Panel 234
18.3 GlobalData Consulting 235
18.4 Contact Us 235
18.5 Disclaimer 235

1.1 List of Tables
Table 1: Cardiovascular Devices Market, China, Revenue ($m), USD Constant, 2005-2020 33
Table 2: Cardiovascular Devices Market, China, Category Contribution by Revenue ($m), 2012 36
Table 3: Cardiovascular Devices Market, China, Category Comparison by Revenue ($m), 2005-2020 38
Table 4: Cardiovascular Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 40
Table 5: Cardiovascular Devices Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 42
Table 6: Cardiovascular Devices Market, China, Volume (Units), 2005-2020 44
Table 7: Cardiovascular Devices Market, China, Volume (Units), Historic, 2005-2012 46
Table 8: Cardiovascular Devices Market, China, Volume (Units), Forecast, 2012-2020 48
Table 9: Cardiovascular Devices Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012 50
Table 10: Cardiac Assist Devices Market, China, Segment Contribution (%), 2012 52
Table 11: Cardiac Assist Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 54
Table 12: Cardiac Assist Devices Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 56
Table 13: Cardiac Assist Devices Market, China, Volume (Units), Historic, 2005-2012 58
Table 14: Cardiac Assist Devices Market, China, Volume (Units), Forecast, 2012-2020 60
Table 15: Cardiac Assist Devices Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012 61
Table 16: Cardiac Assist Devices Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012 63
Table 17: Cardiac Rhythm Management Market, China, Segment Contribution (%), 2012 65
Table 18: Cardiac Rhythm Management Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 67
Table 19: Cardiac Rhythm Management Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 69
Table 20: Cardiac Rhythm Management Market, China, Volume (Units), Historic, 2005-2012 71
Table 21: Cardiac Rhythm Management Market, China, Volume (Units), Forecast, 2012-2020 73
Table 22: Cardiac Rhythm Management Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012 74
Table 23: Cardiac Rhythm Management Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012 76
Table 24: Cardiovascular Monitoring and Diagnostic Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 78
Table 25: Cardiovascular Monitoring and Diagnostic Devices Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 80
Table 26: Cardiovascular Monitoring and Diagnostic Devices Market, China, Volume (Units), Historic, 2005-2012 81
Table 27: Cardiovascular Monitoring and Diagnostic Devices Market, China, Volume (Units), Forecast, 2012-2020 82
Table 28: Cardiovascular Monitoring and Diagnostic Devices Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012 83
Table 29: Cardiovascular Monitoring and Diagnostic Devices Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012 85
Table 30: Cardiovascular Prosthetic Devices Market, China, Segment Contribution (%), 2012 87
Table 31: Cardiovascular Prosthetic Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 89
Table 32: Cardiovascular Prosthetic Devices Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 91
Table 33: Cardiovascular Prosthetic Devices Market, China, Volume (Units), Historic, 2005-2012 93
Table 34: Cardiovascular Prosthetic Devices Market, China, Volume (Units), Forecast, 2012-2020 95
Table 35: Cardiovascular Prosthetic Devices Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012 96
Table 36: Cardiovascular Prosthetic Devices Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012 98
Table 37: Cardiovascular Surgery Market, China, Segment Contribution (%), 2012 100
Table 38: Cardiovascular Surgery Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 102
Table 39: Cardiovascular Surgery Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 104
Table 40: Cardiovascular Surgery Market, China, Volume (Units), Historic, 2005-2012 106
Table 41: Cardiovascular Surgery Market, China, Volume (Units), Forecast, 2012-2020 108
Table 42: Cardiovascular Surgery Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012 109
Table 43: Cardiovascular Surgery Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012 111
Table 44: Electrophysiology Market, China, Segment Contribution (%), 2012 113
Table 45: Electrophysiology Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 115
Table 46: Electrophysiology Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 117
Table 47: Electrophysiology Market, China, Volume (Units), Historic, 2005-2012 119
Table 48: Electrophysiology Market, China, Volume (Units), Forecast, 2012-2020 121
Table 49: Electrophysiology Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012 122
Table 50: Electrophysiology Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012 124
Table 51: External Defibrillators Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 125
Table 52: External Defibrillators Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 126
Table 53: External Defibrillators Market, China, Volume (Units), Historic, 2005-2012 127
Table 54: External Defibrillators Market, China, Volume (Units), Forecast, 2012-2020 128
Table 55: External Defibrillators Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012 129
Table 56: External Defibrillators Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012 131
Table 57: Interventional Cardiology Market, China, Segment Contribution (%), 2012 134
Table 58: Interventional Cardiology Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 136
Table 59: Interventional Cardiology Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 138
Table 60: Interventional Cardiology Market, China, Volume (Units), Historic, 2005-2012 140
Table 61: Interventional Cardiology Market, China, Volume (Units), Forecast, 2012-2020 142
Table 62: Interventional Cardiology Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012 143
Table 63: Interventional Cardiology Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012 145
Table 64: Peripheral Vascular Devices Market, China, Segment Contribution (%), 2012 148
Table 65: Peripheral Vascular Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 150
Table 66: Peripheral Vascular Devices Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 152
Table 67: Peripheral Vascular Devices Market, China, Volume (Units), Historic, 2005-2012 154
Table 68: Peripheral Vascular Devices Market, China, Volume (Units), Forecast, 2012-2020 156
Table 69: Peripheral Vascular Devices Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012 157
Table 70: Peripheral Vascular Devices Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012 159
Table 71: Prosthetic Heart Valves Market, China, Segment Contribution (%), 2012 161
Table 72: Prosthetic Heart Valves Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 163
Table 73: Prosthetic Heart Valves Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 165
Table 74: Prosthetic Heart Valves Market, China, Volume (Units), Historic, 2005-2012 167
Table 75: Prosthetic Heart Valves Market, China, Volume (Units), Forecast, 2012-2020 169
Table 76: Prosthetic Heart Valves Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012 170
Table 77: Prosthetic Heart Valves Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012 172
Table 78: Cardiovascular Devices Market Pipeline Products 179
Table 79: Lepu Medical Technology To Acquire Additional 24.9% Stake In Shaanxi Qinming Medical Instruments 181
Table 80: MicroPort Acquires D-Pulse Medical 183
Table 81: MicroPort Scientific Acquires Winning Forward For US$5.3 Million 184
Table 82: Medtronic Completes Acquisition Of 26.4% Stake In LifeTech Scientific For US$66 Million 185
Table 83: MicroPort Medical Acquires Dongguan Kewei Medical From Savernake Investments For Up To US$17 Million 187
Table 84: AngioDynamics Completes Acquisition Of Rights To Microwave Ablation Technology For US$16 Million 189
Table 85: Vasomedical And PSK Enter Into Joint Venture Agreement To Form VSK Medical 191
Table 86: Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology 192
Table 87: ReFlow Medical Enters Into Distribution Agreement With MicroPort Scientific 193
Table 88: MicroPort Scientific To Form Joint Venture With Sorin 194
Table 89: Sun Biomedical Plans To Enter Into Licensing Agreement With Parvulus Suisse 195
Table 90: Xenios Enters Into Licensing Agreement With Leukocare For Next Generation Extracorporeal Support Systems 196
Table 91: Micell Technologies Enters Into Co-Development Agreement With Hefei Life Science For MiStent SES 197
Table 92: Coherex Medical Enters Into Distribution Agreement With Biosense Webster 198
Table 93: Biosensors Enters Into Licensing Agreement With Eurocor 199
Table 94: Terumo Enters Into Co-Development Agreement With Kaneka For PTA Balloon Catheters 201
Table 95: TriReme Medical Enters Into Distribution Agreement With Weigao Medical Devices 202
Table 96: Terumo Enters Into Agreement With Shanghai AngioCare Medical Technolgy 203
Table 97: Biosensors Extends Licensing Agreement With Terumo For BioMatrix Technology 204
Table 98: MicroPort Medical Forms Joint Venture With MicroPort Endovascular 205
Table 99: Boston Scientific Enters Into Agreement With Philips Healthcare 206
Table 100: CardioComm Solutions Enters Into Co-Development Agreement With Monebo Technologies For ECG Interpretation Software 207
Table 101: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 230

1.2 List of Figures
Figure 1: Cardiovascular Devices Market, China, Revenue ($m), USD Constant, 2005-2020 32
Figure 2: Cardiovascular Devices Market, China, Revenue Mix ($m), 2012 34
Figure 3: Cardiovascular Devices Market, China, Category Contribution (%), 2012 35
Figure 4: Cardiovascular Devices Market, China, Category Comparison by Revenue ($m), 2005-2020 37
Figure 5: Cardiovascular Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 39
Figure 6: Cardiovascular Devices Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 41
Figure 7: Cardiovascular Devices Market, China, Volume (Units), 2005-2020 43
Figure 8: Cardiovascular Devices Market, China, Volume (Units), Historic, 2005-2012 45
Figure 9: Cardiovascular Devices Market, China, Volume (Units), Forecast, 2012-2020 47
Figure 10: Cardiovascular Devices Market, China, Company Share (%), 2012 49
Figure 11: Cardiac Assist Devices Market, China, Revenue Mix ($m), 2012 51
Figure 12: Cardiac Assist Devices Market, China, Segment Contribution (%), 2012 52
Figure 13: Cardiac Assist Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 53
Figure 14: Cardiac Assist Devices Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 55
Figure 15: Cardiac Assist Devices Market, China, Volume (Units), Historic, 2005-2012 57
Figure 16: Cardiac Assist Devices Market, China, Volume (Units), Forecast, 2012-2020 59
Figure 17: Cardiac Assist Devices Market, China, Company Share (%), 2012 62
Figure 18: Cardiac Rhythm Management Market, China, Revenue Mix ($m), 2012 64
Figure 19: Cardiac Rhythm Management Market, China, Segment Contribution (%), 2012 65
Figure 20: Cardiac Rhythm Management Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 66
Figure 21: Cardiac Rhythm Management Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 68
Figure 22: Cardiac Rhythm Management Market, China, Volume (Units), Historic, 2005-2012 70
Figure 23: Cardiac Rhythm Management Market, China, Volume (Units), Forecast, 2012-2020 72
Figure 24: Cardiac Rhythm Management Market, China, Company Share (%), 2012 75
Figure 25: Cardiovascular Monitoring and Diagnostic Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 77
Figure 26: Cardiovascular Monitoring and Diagnostic Devices Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 79
Figure 27: Cardiovascular Monitoring and Diagnostic Devices Market, China, Volume (Units), Historic, 2005-2012 81
Figure 28: Cardiovascular Monitoring and Diagnostic Devices Market, China, Volume (Units), Forecast, 2012-2020 82
Figure 29: Cardiovascular Monitoring and Diagnostic Devices Market, China, Company Share (%), 2012 84
Figure 30: Cardiovascular Prosthetic Devices Market, China, Revenue Mix ($m), 2012 86
Figure 31: Cardiovascular Prosthetic Devices Market, China, Segment Contribution (%), 2012 87
Figure 32: Cardiovascular Prosthetic Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 88
Figure 33: Cardiovascular Prosthetic Devices Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 90
Figure 34: Cardiovascular Prosthetic Devices Market, China, Volume (Units), Historic, 2005-2012 92
Figure 35: Cardiovascular Prosthetic Devices Market, China, Volume (Units), Forecast, 2012-2020 94
Figure 36: Cardiovascular Prosthetic Devices Market, China, Company Share (%), 2012 97
Figure 37: Cardiovascular Surgery Market, China, Revenue Mix ($m), 2012 99
Figure 38: Cardiovascular Surgery Market, China, Segment Contribution (%), 2012 100
Figure 39: Cardiovascular Surgery Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 101
Figure 40: Cardiovascular Surgery Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 103
Figure 41: Cardiovascular Surgery Market, China, Volume (Units), Historic, 2005-2012 105
Figure 42: Cardiovascular Surgery Market, China, Volume (Units), Forecast, 2012-2020 107
Figure 43: Cardiovascular Surgery Market, China, Company Share (%), 2012 110
Figure 44: Electrophysiology Market, China, Revenue Mix ($m), 2012 112
Figure 45: Electrophysiology Market, China, Segment Contribution (%), 2012 113
Figure 46: Electrophysiology Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 114
Figure 47: Electrophysiology Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 116
Figure 48: Electrophysiology Market, China, Volume (Units), Historic, 2005-2012 118
Figure 49: Electrophysiology Market, China, Volume (Units), Forecast, 2012-2020 120
Figure 50: Electrophysiology Market, China, Company Share (%), 2012 123
Figure 51: External Defibrillators Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 125
Figure 52: External Defibrillators Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 126
Figure 53: External Defibrillators Market, China, Volume (Units), Historic, 2005-2012 127
Figure 54: External Defibrillators Market, China, Volume (Units), Forecast, 2012-2020 128
Figure 55: External Defibrillators Market, China, Company Share (%), 2012 130
Figure 56: Interventional Cardiology Market, China, Revenue Mix ($m), 2012 132
Figure 57: Interventional Cardiology Market, China, Segment Contribution (%), 2012 133
Figure 58: Interventional Cardiology Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 135
Figure 59: Interventional Cardiology Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 137
Figure 60: Interventional Cardiology Market, China, Volume (Units), Historic, 2005-2012 139
Figure 61: Interventional Cardiology Market, China, Volume (Units), Forecast, 2012-2020 141
Figure 62: Interventional Cardiology Market, China, Company Share (%), 2012 144
Figure 63: Peripheral Vascular Devices Market, China, Revenue Mix ($m), 2012 146
Figure 64: Peripheral Vascular Devices Market, China, Segment Contribution (%), 2012 147
Figure 65: Peripheral Vascular Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 149
Figure 66: Peripheral Vascular Devices Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 151
Figure 67: Peripheral Vascular Devices Market, China, Volume (Units), Historic, 2005-2012 153
Figure 68: Peripheral Vascular Devices Market, China, Volume (Units), Forecast, 2012-2020 155
Figure 69: Peripheral Vascular Devices Market, China, Company Share (%), 2012 158
Figure 70: Prosthetic Heart Valves Market, China, Revenue Mix ($m), 2012 160
Figure 71: Prosthetic Heart Valves Market, China, Segment Contribution (%), 2012 161
Figure 72: Prosthetic Heart Valves Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 162
Figure 73: Prosthetic Heart Valves Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 164
Figure 74: Prosthetic Heart Valves Market, China, Volume (Units), Historic, 2005-2012 166
Figure 75: Prosthetic Heart Valves Market, China, Volume (Units), Forecast, 2012-2020 168
Figure 76: Prosthetic Heart Valves Market, China, Company Share (%), 2012 171
Figure 77: GlobalData Epidemiology-Based Forecasting Model 232
Figure 78: GlobalData Capital Equipment-Based Forecasting Model 233
Figure 79: Primary Interviews by Participant Type (%) 234

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Transplant Diagnostics: Technologies and Global Markets

Transplant Diagnostics: Technologies and Global Markets

  • $ 6650
  • Industry report
  • October 2016
  • by BCC Research

Use this report to: - Identify key market segments - Gain insight into the trends, gaps, and opportunities in each of the micro markets. - Learn about the key market dynamics and the factors impacting ...

Implantable Medical Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Implantable Medical Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • August 2016
  • by Transparency Market Research

This report on implantable medical devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture ...

Urology Surgical Instruments Market by Product, Application - Global Forecast to 2021

Urology Surgical Instruments Market by Product, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global urology surgical instruments market is expected to reach USD 11.48 billion by 2021 from USD 7.74 billion in 2016, growing at a CAGR of 8.2% from 2016 to 2021. The consumables and accessories ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.